Clinical Manifestations
Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue. We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia 2024-12, Vol.20 Suppl 3, p.e088276 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | e088276 |
container_title | Alzheimer's & dementia |
container_volume | 20 Suppl 3 |
creator | Tastevin, Maud Lavoie, Monica Laforce, Jr, Robert |
description | Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue.
We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year span (42 logopenic, 21 non-fluent/agrammatic and 19 semantic PPAs) and collected data from 5 domains (language, cognition, motor, psychiatric, functional) at 5 time points from onset to death. Logistical regression analyses and repeated measures ANOVAs were conducted to delineate the longitudinal profile of each variant PPA.
All patients presented anomia and executive impairments over time. Language deficits tended to be more significant for lvPPA, particularly after 3 years of evolution and this group showed broader cognitive impairments. Psychiatric symptoms were more frequent in svPPA and nfvPPA, particularly after 5 years of evolution. Motor features predominantly affected patients with nfvPPA after 2 years of evolution. Overall functional abilities remained preserved the longest in svPPA (up to 5 years).
To our knowledge, this naturalistic study on all major PPA symptoms over a 10-year span from onset to death is the largest to date. Data from this study can help clinicians better inform and prepare their patients for future challenges as well as design more focused interventions. |
doi_str_mv | 10.1002/alz.088276 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3151203426</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3151203426</sourcerecordid><originalsourceid>FETCH-LOGICAL-p560-3a52089b172b638d1f2b1a19d4bf987844fd0f7733420f4944ecfb454295ba003</originalsourceid><addsrcrecordid>eNpNj7tLBDEYxIMo3kMbGzuxtNnz-_JOKcupByc21y_JbgKR7MPNbaF_vQueYDVT_GaGIeQGYYMA9NGm7w1oTZU8I0sUghaCKnP-zy_IKucPAA4axSVZMKMESIQluS1T7GJt0_2b7WLw-WiPse_yFbkINmV_fdI1OTxvD-VrsX9_2ZVP-2IQEgpmBQVtHCrqJNMNBurQomm4C0YrzXloICjFGKcQuOHc18FxwakRzgKwNXn4rR3G_nOa16s25tqnZDvfT7liKJDCnJYzendCJ9f6phrG2Nrxq_r7wn4ARn1Hmw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3151203426</pqid></control><display><type>article</type><title>Clinical Manifestations</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>Wiley Online Library All Journals</source><source>PubMed Central</source><creator>Tastevin, Maud ; Lavoie, Monica ; Laforce, Jr, Robert</creator><creatorcontrib>Tastevin, Maud ; Lavoie, Monica ; Laforce, Jr, Robert</creatorcontrib><description>Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue.
We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year span (42 logopenic, 21 non-fluent/agrammatic and 19 semantic PPAs) and collected data from 5 domains (language, cognition, motor, psychiatric, functional) at 5 time points from onset to death. Logistical regression analyses and repeated measures ANOVAs were conducted to delineate the longitudinal profile of each variant PPA.
All patients presented anomia and executive impairments over time. Language deficits tended to be more significant for lvPPA, particularly after 3 years of evolution and this group showed broader cognitive impairments. Psychiatric symptoms were more frequent in svPPA and nfvPPA, particularly after 5 years of evolution. Motor features predominantly affected patients with nfvPPA after 2 years of evolution. Overall functional abilities remained preserved the longest in svPPA (up to 5 years).
To our knowledge, this naturalistic study on all major PPA symptoms over a 10-year span from onset to death is the largest to date. Data from this study can help clinicians better inform and prepare their patients for future challenges as well as design more focused interventions.</description><identifier>ISSN: 1552-5279</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.088276</identifier><identifier>PMID: 39750610</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Aphasia, Primary Progressive ; Disease Progression ; Executive Function - physiology ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Neuropsychological Tests - statistics & numerical data</subject><ispartof>Alzheimer's & dementia, 2024-12, Vol.20 Suppl 3, p.e088276</ispartof><rights>2024 The Alzheimer's Association. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39750610$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tastevin, Maud</creatorcontrib><creatorcontrib>Lavoie, Monica</creatorcontrib><creatorcontrib>Laforce, Jr, Robert</creatorcontrib><title>Clinical Manifestations</title><title>Alzheimer's & dementia</title><addtitle>Alzheimers Dement</addtitle><description>Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue.
We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year span (42 logopenic, 21 non-fluent/agrammatic and 19 semantic PPAs) and collected data from 5 domains (language, cognition, motor, psychiatric, functional) at 5 time points from onset to death. Logistical regression analyses and repeated measures ANOVAs were conducted to delineate the longitudinal profile of each variant PPA.
All patients presented anomia and executive impairments over time. Language deficits tended to be more significant for lvPPA, particularly after 3 years of evolution and this group showed broader cognitive impairments. Psychiatric symptoms were more frequent in svPPA and nfvPPA, particularly after 5 years of evolution. Motor features predominantly affected patients with nfvPPA after 2 years of evolution. Overall functional abilities remained preserved the longest in svPPA (up to 5 years).
To our knowledge, this naturalistic study on all major PPA symptoms over a 10-year span from onset to death is the largest to date. Data from this study can help clinicians better inform and prepare their patients for future challenges as well as design more focused interventions.</description><subject>Aged</subject><subject>Aphasia, Primary Progressive</subject><subject>Disease Progression</subject><subject>Executive Function - physiology</subject><subject>Female</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuropsychological Tests - statistics & numerical data</subject><issn>1552-5279</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNj7tLBDEYxIMo3kMbGzuxtNnz-_JOKcupByc21y_JbgKR7MPNbaF_vQueYDVT_GaGIeQGYYMA9NGm7w1oTZU8I0sUghaCKnP-zy_IKucPAA4axSVZMKMESIQluS1T7GJt0_2b7WLw-WiPse_yFbkINmV_fdI1OTxvD-VrsX9_2ZVP-2IQEgpmBQVtHCrqJNMNBurQomm4C0YrzXloICjFGKcQuOHc18FxwakRzgKwNXn4rR3G_nOa16s25tqnZDvfT7liKJDCnJYzendCJ9f6phrG2Nrxq_r7wn4ARn1Hmw</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Tastevin, Maud</creator><creator>Lavoie, Monica</creator><creator>Laforce, Jr, Robert</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Clinical Manifestations</title><author>Tastevin, Maud ; Lavoie, Monica ; Laforce, Jr, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p560-3a52089b172b638d1f2b1a19d4bf987844fd0f7733420f4944ecfb454295ba003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Aphasia, Primary Progressive</topic><topic>Disease Progression</topic><topic>Executive Function - physiology</topic><topic>Female</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuropsychological Tests - statistics & numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tastevin, Maud</creatorcontrib><creatorcontrib>Lavoie, Monica</creatorcontrib><creatorcontrib>Laforce, Jr, Robert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Alzheimer's & dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tastevin, Maud</au><au>Lavoie, Monica</au><au>Laforce, Jr, Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Manifestations</atitle><jtitle>Alzheimer's & dementia</jtitle><addtitle>Alzheimers Dement</addtitle><date>2024-12</date><risdate>2024</risdate><volume>20 Suppl 3</volume><spage>e088276</spage><pages>e088276-</pages><issn>1552-5279</issn><eissn>1552-5279</eissn><abstract>Patients with Primary Progressive Aphasias (PPAs) almost systematically inquire about the longitudinal evolution of their disease in clinics but very little research exists on the issue.
We studied 82 PPA patients from the Research Chair on PPA - Fondation de la Famille Lemaire Cohort over a 10-year span (42 logopenic, 21 non-fluent/agrammatic and 19 semantic PPAs) and collected data from 5 domains (language, cognition, motor, psychiatric, functional) at 5 time points from onset to death. Logistical regression analyses and repeated measures ANOVAs were conducted to delineate the longitudinal profile of each variant PPA.
All patients presented anomia and executive impairments over time. Language deficits tended to be more significant for lvPPA, particularly after 3 years of evolution and this group showed broader cognitive impairments. Psychiatric symptoms were more frequent in svPPA and nfvPPA, particularly after 5 years of evolution. Motor features predominantly affected patients with nfvPPA after 2 years of evolution. Overall functional abilities remained preserved the longest in svPPA (up to 5 years).
To our knowledge, this naturalistic study on all major PPA symptoms over a 10-year span from onset to death is the largest to date. Data from this study can help clinicians better inform and prepare their patients for future challenges as well as design more focused interventions.</abstract><cop>United States</cop><pmid>39750610</pmid><doi>10.1002/alz.088276</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-5279 |
ispartof | Alzheimer's & dementia, 2024-12, Vol.20 Suppl 3, p.e088276 |
issn | 1552-5279 1552-5279 |
language | eng |
recordid | cdi_proquest_miscellaneous_3151203426 |
source | MEDLINE; PubMed Central Open Access; Wiley-Blackwell Open Access Titles; Wiley Online Library All Journals; PubMed Central |
subjects | Aged Aphasia, Primary Progressive Disease Progression Executive Function - physiology Female Humans Longitudinal Studies Male Middle Aged Neuropsychological Tests - statistics & numerical data |
title | Clinical Manifestations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A08%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Manifestations&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Tastevin,%20Maud&rft.date=2024-12&rft.volume=20%20Suppl%203&rft.spage=e088276&rft.pages=e088276-&rft.issn=1552-5279&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.088276&rft_dat=%3Cproquest_pubme%3E3151203426%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3151203426&rft_id=info:pmid/39750610&rfr_iscdi=true |